跳至主要内容
临床试验/NCT05164861
NCT05164861已完成不适用

Assessment of Safety and Efficacy of Non-alcoholic Pasteurized Beverage Based on Kombucha, Enriched With Inulin and Vitamins in Patients With Constipations

Vasily Isakov2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Change of number bowel movements

研究概览

简要总结

Single centre, open-label, non-randomized study is planned to proof the concept of safety and efficacy of newly developed specialized food product - non-alcoholic pasteurized beverage based on kombucha, enriched with inulin and vitamins in patients with constipations

详细描述

This single-center open-label non-randomized study is planned to proof the concept on safety and efficacy of newly developed specialized food product - non-alcoholic pasteurized beverage based on kombucha, enriched with inulin and vitamins in patients with irritable bowel syndrome with constipations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • willingness to participate (based on signed informed consent form)
  • irritable bowel syndrome with predominant constipation, per Rome IV criteria (Recurrent abdominal pain on average at least 1 day/week in the last 3 months, associated with two or more of the following criteria: related to defecation; associated with a change in frequency of stool; associated with a change in form (appearance) of stool - Bristol stool scale types 1 or
  • Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis),

排除标准

  • pregnant or breast-feeding women;
  • intolerance of kombucha or any component of the product;
  • history of abdominal surgery;
  • the use of concomitant medications able to affect bowel motility;
  • general condition of a patient making the appropriateness of his participation in the study questionable;
  • chronic decompensated disorders of any organs and systems;
  • mean daily caloric intake less than 800 kcal and more than 6000 kcal
  • inability to follow standard iso-caloric diet and standard volume of water consumption (1.5-2 litres a day)

结局指标

主要结局

Change of number bowel movements

时间窗: two weeks

Number of bowel movements per week will be assessed per patients self report

Change of stool type

时间窗: a week

Stool type assessed per the Bristol stool scale (from type 1 to type 7; where type 1 - separate hard lumps, like nuts, type 7 - watery, no solid pieces, entirely liquid stool - diarrhoea)

次要结局

  • Adverse events(two weeks)

研究者

发起方
Vasily Isakov
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Vasily Isakov

Professor, MD, PhD, AGAF

Russian Academy of Medical Sciences

研究点 (2)

Loading locations...

相似试验